Sign Up to like & get
recommendations!
0
Published in 2017 at "Biomaterials"
DOI: 10.1016/j.biomaterials.2017.09.009
Abstract: Currently, intratumoral injection of an oncolytic adenovirus (Ad) is the conventional administration route in clinical trials. Nonetheless, the locally administered Ad disseminates to the surrounding nontarget tissues and has short biological activity due to immunogenicity…
read more here.
Keywords:
oad trail;
trail;
immune response;
oncolytic adenovirus ... See more keywords